Psoriasis is a kind of common chronic, recurrent and inflammatory disease, which etiological factors and mechanism are not clear yet. Psoriasisi was confirmed as a kind of autoimmune disease with inflammation by research of its immune pathogenesis.The therapentic principle is based on anti-inflammtory and suppress proliferation. Generlly, for most of the psoriasis patients, topical treatment is the first choice. The first-line medicines including coal-tar, dithrand, corticosteroid, Vitamin D3 analogues, retinoids and calcineurin inhibitors. With the study of medicines, some new formulation of drugs are being developed. |